Oric Pharmaceuticals Total Operating Expenses History
| ORIC Stock | USD 11.10 -0.03 -0.27% |
Total Operating Expenses | First Reported 2019-03-31 | Previous Quarter 36.7 M | Current Value 34.2 M | Quarterly Volatility 10.4 M |
Macro event markers
Latest Oric Pharmaceuticals' Total Operating Expenses Growth Pattern
Oric Pharmaceuticals's Total Operating Expenses across 9 years of filings is presented below. Periods of stability and acceleration are both visible in the long-term series. Contextualizing the current level against the historical series helps gauge whether it is elevated or compressed. Evaluating Oric Pharmaceuticals' Total Operating Expenses against peer averages adds another layer of context. The curvature of Oric Pharmaceuticals' Total Operating Expenses trend adds context beyond what the raw numbers convey.
| Total Operating Expenses | 10 Years Trend |
|
All figures are presented for informational review.
Total Operating Expenses |
| Timeline |
Total Operating Expenses Trend Statistics
| Arithmetic Mean | 55,762,127 | |
| Geometric Mean | 41,372,805 | |
| Coefficient Of Variation | 80.29 | |
| Mean Deviation | 39,359,209 | |
| Median | 22,371,000 | |
| Standard Deviation | 44,769,001 | |
| Sample Variance | 2004.3T | |
| Range | 120.1M | |
| R-Value | 0.85 | |
| Mean Square Error | 581.3T | |
| R-Squared | 0.73 | |
| Significance | 0.000013 | |
| Slope | 7,564,841 | |
| Total Sum of Squares | 32068.2T |
Oric Pharmaceuticals Total Operating Expenses History
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Selling And Marketing Expenses | 1.2 M | 1.1 M | |
| Other Operating Expenses | 143 M | 87.4 M | |
| Total Operating Expenses | 141.8 M | 86.7 M |
Methodology, Assumptions & Data Sources
Below is Oric Pharmaceuticals's Total Operating Expenses history. A strong fit to a straight line suggests the trend is dependable.
Inputs for Oric Pharmaceuticals come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Analyst inputs may be included when coverage is available. Some fields can appear with publication lag. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.